Literature DB >> 18398509

Congenital myasthenia-related AChR delta subunit mutation interferes with intersubunit communication essential for channel gating.

Xin-Ming Shen1, Taku Fukuda, Kinji Ohno, Steven M Sine, Andrew G Engel.   

Abstract

Congenital myasthenias (CMs) arise from defects in neuromuscular junction-associated proteins. Deciphering the molecular bases of the CMs is required for therapy and illuminates structure-function relationships in these proteins. Here, we analyze the effects of a mutation in 1 of 4 homologous subunits in the AChR from a CM patient, a Leu to Pro mutation at position 42 of the delta subunit. The mutation is located in a region of contact between subunits required for rapid opening of the AChR channel and impedes the rate of channel opening. Substitutions of Gly, Lys, or Asp for deltaL42, or substitutions of Pro along the local protein chain, also slowed channel opening. Substitution of Pro for Leu in the epsilon subunit slowed opening, whereas this substitution had no effect in the beta subunit and actually sped opening in the alpha subunit. Analyses of energetic coupling between residues at the subunit interface showed that deltaL42 is functionally linked to alphaT127, a key residue in the adjacent alpha subunit required for rapid channel opening. Thus, deltaL42 is part of an intersubunit network that enables ACh binding to rapidly open the AChR channel, which may be compromised in patients with CM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398509      PMCID: PMC2289798          DOI: 10.1172/JCI34527

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Amplification of neuromuscular transmission by postjunctional folds.

Authors:  A R Martin
Journal:  Proc Biol Sci       Date:  1994-12-22       Impact factor: 5.349

2.  A quantitative study of end-plate potentials in isolated human muscle.

Authors:  D Elmqvist; D M Quastel
Journal:  J Physiol       Date:  1965-06       Impact factor: 5.182

3.  Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.

Authors:  Kinji Ohno; Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Joan Brengman; C Michel Harper; Akira Tsujino; Margherita Milone
Journal:  Am J Hum Genet       Date:  2002-01-14       Impact factor: 11.025

4.  Mutation causing severe myasthenia reveals functional asymmetry of AChR signature cystine loops in agonist binding and gating.

Authors:  Xin-Ming Shen; Kinji Ohno; Akira Tsujino; Joan M Brengman; Monique Gingold; Steven M Sine; Andrew G Engel
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

5.  Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.

Authors:  K Ohno; A Tsujino; J M Brengman; C M Harper; Z Bajzer; B Udd; R Beyring; S Robb; F J Kirkham; A G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

6.  Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate.

Authors:  D Colquhoun; B Sakmann
Journal:  J Physiol       Date:  1985-12       Impact factor: 5.182

7.  Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies.

Authors:  D M Fambrough; A G Engel; T L Rosenberry
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Single acetylcholine-activated channels show burst-kinetics in presence of desensitizing concentrations of agonist.

Authors:  B Sakmann; J Patlak; E Neher
Journal:  Nature       Date:  1980-07-03       Impact factor: 49.962

9.  Myasthenic syndrome caused by mutation of the SCN4A sodium channel.

Authors:  Akira Tsujino; Chantal Maertens; Kinji Ohno; Xin-Ming Shen; Taku Fukuda; C Michael Harper; Stephen C Cannon; Andrew G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-23       Impact factor: 11.205

10.  Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.

Authors:  A G Engel; J M Lindstrom; E H Lambert; V A Lennon
Journal:  Neurology       Date:  1977-04       Impact factor: 9.910

View more
  17 in total

1.  Altered plasmodial surface anion channel activity and in vitro resistance to permeating antimalarial compounds.

Authors:  Godfrey Lisk; Margaret Pain; Morgan Sellers; Philip A Gurnev; Ajay D Pillai; Sergey M Bezrukov; Sanjay A Desai
Journal:  Biochim Biophys Acta       Date:  2010-05-06

2.  Myasthenic syndrome AChRα C-loop mutant disrupts initiation of channel gating.

Authors:  Xin-Ming Shen; Joan M Brengman; Steven M Sine; Andrew G Engel
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 3.  End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease.

Authors:  Steven M Sine
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 4.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

5.  Investigation of Congenital Myasthenia Reveals Functional Asymmetry of Invariant Acetylcholine Receptor (AChR) Cys-loop Aspartates.

Authors:  Xin-Ming Shen; Joan Brengman; David Neubauer; Steven M Sine; Andrew G Engel
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

Review 6.  Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

Review 7.  Congenital myasthenic syndromes in 2012.

Authors:  Andrew G Engel
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 8.  Further observations in congenital myasthenic syndromes.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

9.  Functional and morphological evidence of age-related denervation in rat laryngeal muscles.

Authors:  Colleen A McMullen; Francisco H Andrade
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-02-17       Impact factor: 6.053

Review 10.  What have we learned from the congenital myasthenic syndromes.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  J Mol Neurosci       Date:  2009-08-18       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.